Bull looks for Alkermes to bounce

By
A A A
Share |

The bears have driven Alkermes to a key support level, and now one investor is positioning for a rebound.

ALKS ALKS rose 3.13 percent to $11.22 in afternoon trading. The drug-delivery stock is down 20 percent since March 15, when it gapped higher on optimism about the Bydureon diabetes treatment. Two months later, it plunged on a weak earnings report and has been trapped below $12 since.

Today's option trade, known as a bullish combination, will mimic a long position in the stock and appeared after ALKS bounced off its 200-day moving average. The strategy will double the investor's money for every $0.25 that the stock trades over $12.75 and lose money below $10.

The company is scheduled to make a presentation at the Bank of America Merrill Lynch Small and Mid-Cap Conference at 2:30 p.m. ET today and at the Jefferies Global Life Sciences Conference at 4:30 p.m. ET tomorrow.

Overall options volume in ALKS is 30 times greater than average so far today.

 

(Chart courtesy of tradeMONSTER )

 



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.


This article appears in: Investing , Options

Referenced Stocks: ALKS

optionMONSTER

optionMONSTER

More from optionMONSTER:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

89,970,926
  • $16.15 ▲ 0.12%
77,131,582
  • $58.94 ▼ 1.31%
67,336,935
  • $26.56 ▲ 1.68%
48,814,124
  • $86.20 ▲ 0.02%
47,526,126
  • $23.21 ▲ 0.78%
44,660,424
  • $23.91 ▲ 6.36%
38,799,699
  • $4.289 ▲ 4.36%
36,199,890
  • $40.01 ▼ 0.97%
As of 4/17/2014, 04:07 PM